This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Sputnik Light is the first component of Sputnik V
The facility will produce 150 million vaccine doses per year
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
Subscribe To Our Newsletter & Stay Updated
